Meperidine clinical trials
Meperidine is named as an intervention in 3 current clinical trials in our Turkey and Singapore registers. None are recruiting at the moment. The most common phase is Not applicable. The sponsor with the most trials is Istanbul Medipol University Hospital (2). The most-studied condition is Postoperative Pain After Arthroscopic Knee Surgery.
Where Meperidine is approved
All regulators →Of the three regulators tracked here, the first to approve Meperidine was the US, on 10 Nov 1942.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Meperidine
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Meperidine works
All drug targets →- Mu opioid receptor agonist AgonistTarget: OPRM1 opioid receptor mu 1✓ In ChEMBL and the Guide to Pharmacology
- Postpartum depressionPhase 2/3
- Acute graft versus host diseasePhase 2
- Chronic graft versus host diseasePhase 2
- Graft versus host diseasePhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL607, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3.1), ligand 7221, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Meperidine
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Meperidine
- ATC code
- N02AB02
- ChEMBL
- CHEMBL607
- DrugBank
- DB00454
- PubChem CID
- 4058
- CAS number
- 57-42-1
- FDA UNII
- 9E338QE28F
- Wikidata
- Q55434
- Wikipedia
- Pethidine
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Meperidine
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Adductor Canal Block Versus Parasartorial Compartment Block for Pain Relief and Recovery After Arthroscopic Knee Surgery
NCT07790393 · ClinicalTrials.gov ↗ · Postoperative Pain After Arthroscopic Knee Surgery
|
Not applicable | Not yet open | Istanbul Medipol University Hospital | Turkey |
|
Quadro-Iliac Plane Block for Pain Control After Posterior Spinal Instrumentation Surgery
NCT07711522 · ClinicalTrials.gov ↗ · Posterior Spinal Instrumentation Patients
|
Early Phase 1 | Not yet open | Istanbul Medipol University Hospital | Turkey |
|
CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)
NCT03167905 · ClinicalTrials.gov ↗ · Depression, Postpartum, Analgesia, Obstetrical, Anesthesia, Obstetrical
|
Phase 2/3 | Active, closed | KK Women's and Children's Hospital | Singapore |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Meperidine across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Supply shortages
- Meperidine Hydrochloride InjectionUS (FDA) · Current · updated 21 Oct 2026
Conditions studied with Meperidine
5 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Istanbul Medipol University Hospital | 2 |
| KK Women's and Children's Hospital | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Turkey | 2 | 0 |
| Clinical trials in Singapore | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Meperidine trials
How many clinical trials are testing Meperidine?
3 current trials in our Turkey and Singapore registers name Meperidine as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Meperidine trials recruiting patients?
Not at the moment. None of the 3 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Who sponsors Meperidine clinical trials?
Istanbul Medipol University Hospital (2) and KK Women's and Children's Hospital (1). The number in brackets is how many trials each organisation leads.
Is there a Meperidine shortage?
The registers we track list 1 entry for Meperidine: US FDA: current. Shortages are product- and country-specific; check with a pharmacist.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Meperidine works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Meperidine works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Meperidine (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.